Skip to main content
. 2021 Mar 15;10(8):2627–2635. doi: 10.1002/cam4.3789

FIGURE 1.

FIGURE 1

(A) Progression‐Free Survival (PFS), and Overall Survival (OS) in months after first immunotherapy for entire DFCI mucosal melanoma cohort. (B) Duration of disease control (DDC)